Celestica (CLS)
305.28
-29.47 (-8.80%)
NYSE· Last Trade: Jul 26th, 9:58 AM EDT
These AI stocks should directly benefit from Alphabet's increasing capex.
Via The Motley Fool · July 26, 2026
Join us as we dissect Celestica's potential in the rapidly growing AI infrastructure sector. Is this stock a hidden gem or a risky bet? Tune in to find out!
Via The Motley Fool · July 22, 2026
Celestica Inc (NYSE:CLS) Screens as a High-Growth CAN SLIM Leader With Accelerating Momentumchartmill.com
Via Chartmill · July 17, 2026
Celestica Inc. (NYSE:CLS): A High Growth Stock With a Strong Technical Setupchartmill.com
Via Chartmill · July 14, 2026
Celestica Inc. (NYSE:CLS): A Strong Candidate for Growth at a Reasonable Pricechartmill.com
Via Chartmill · July 6, 2026
Celestica Inc. (NYSE:CLS) Scores a Perfect CANSLIM Screenchartmill.com
Via Chartmill · June 26, 2026
CELESTICA INC (NYSE:CLS) – The Textbook Affordable Growth Stockchartmill.com
Via Chartmill · June 9, 2026
Celestica Inc. (NYSE:CLS) Passes CAN SLIM Screening with Surging Earnings and 97 RS Ratingchartmill.com
Via Chartmill · June 5, 2026
Celestica Inc. (NYSE:CLS): A GARP Play That Blends High Growth with an Affordable Valuationchartmill.com
Via Chartmill · May 18, 2026
These two AI stocks have struggled lately, but their solid earnings growth potential suggests they can step on the gas again.
Via The Motley Fool · July 11, 2026
The iShares North American Tech ETF (IGM) has gained nearly 20% year to date, outpacing the QQQ's 13% return, with Canadian holdings like Shopify and Celestica contributing to its performance.
Via MarketBeat · June 10, 2026
These AI infrastructure companies are poised to profit from the massive compute, networking, and data center build-out required to power Claude's next phase of growth.
Via The Motley Fool · June 7, 2026
Celestica Inc (NYSE:CLS) Triggers CAN SLIM Breakout Criteria Showing Explosive Growth Potentialchartmill.com
Via Chartmill · May 15, 2026
Celestica Inc. (NYSE:CLS) Stands Out as a Strong CAN SLIM Growth Candidatechartmill.com
Via Chartmill · April 23, 2026
Discover 3 up-and-coming stocks flying under the radar, including AI and fintech companies with strong growth and long-term upside
Via MarketBeat · June 1, 2026
Indivior develops buprenorphine-based treatments for opioid dependence, serving markets in the US, UK, and worldwide.
Via The Motley Fool · May 30, 2026
Celestica's AI growth story is accelerating, but after a massive stock run, investors have to decide whether the upside still justifies the risk.
Via The Motley Fool · May 12, 2026
Celestica Inc (NYSE:CLS) Passes the "Caviar Cruise" Quality Investing Screenchartmill.com
Via Chartmill · April 21, 2026
Celestica Inc (NYSE:CLS) Screens as a CAN SLIM Growth Leaderchartmill.com
Via Chartmill · April 2, 2026

The aggressive build-out of AI data centers has supercharged Celestica stock over the past year.
Via The Motley Fool · May 6, 2026
Celestica's Q1 report arrived with strong results, but that hasn't been enough for investors.
Via The Motley Fool · April 28, 2026
Celestica (CLS) Q1 2026 Earnings Transcript
Via The Motley Fool · April 28, 2026
What's going on in today's after hours sessionchartmill.com
Via Chartmill · April 27, 2026

Via MarketBeat · April 27, 2026
ASML raised its 2026 guidance, expecting stronger capital investments from AI hardware companies to meet robust end-market demand.
Via The Motley Fool · April 21, 2026